Shares of Mast Therapeutics Inc (NYSEMKT:MSTX) ended Tuesday session in red amid volatile trading. The shares closed down -0.073 points or -12.54% at $0.509 with 17.65 million shares getting traded. Post opening the session at $0.59, the shares hit an intraday low of $0.35 and an intraday high of $0.60 and the price vacillated in this range throughout the day. The company has a market cap of $102.36 million and the numbers of outstanding shares have been calculated to be 211.82 million shares.
Mast Therapeutics Inc (MSTX) on Sept. 6, 2016 announced that it is joining other industry leaders, patient advocacy groups, researchers, clinicians, policymakers, and foundations in a collective effort to improve sickle cell disease (SCD) care, early diagnosis, treatment, and research both in the United States and globally. The newly formed Sickle Cell Disease Coalition is spearheaded by the American Society of Hematology (ASH) and aspires to change the status quo of SCD treatment and awareness.
SCD is an inherited, lifelong disorder characterized by red blood cells that become rigid and sickle-shaped, which causes them to stick together and block the flow of oxygen to the body, leading to intense pain and other serious issues such as stroke, organ failure, and death. SCD affects approximately 100,000 Americans and millions worldwide. It is a growing health problem and it is estimated that by 2050 the number of people with SCD will increase by 30 percent globally. Over the last century, several important discoveries have led to improved diagnosis and treatments, but people with the disease still have severe complications and shorter life expectancy. Many are unable to access the care they need and live with pain and disability due to a lack of effective treatment options.
Shares of Opko Health Inc. (NYSE:OPK) ended Tuesday session in green amid volatile trading. The shares closed up +0.15 points or 1.52% at $10.04 with 4.47 million shares getting traded. Post opening the session at $9.80, the shares hit an intraday low of $9.76 and an intraday high of $10.09 and the price vacillated in this range throughout the day. The company has a market cap of $5.61 billion and the numbers of outstanding shares have been calculated to be 550.38 million shares.
Opko Health Inc. (OPK) on September 13, 2016 announced the appointment of Jane Pine Wood, Esq. as Chief Legal and Compliance Officer of its wholly owned subsidiary, BioReference Laboratories, effective October 1, 2016.
Ms. Wood is a nationally respected healthcare attorney who has been practicing law for 29 years. She specializes in laboratory regulatory and compliance matters, and has counseled more than 500 pathology groups and 350 clinical laboratories. For the past 28 years she has been with the multi-state law firm McDonald Hopkins LLC, where she is a member of the firm’s board of directors. Ms. Wood is a frequent speaker at national and state laboratory and pathology meetings, is a contributor to association publications and is regularly quoted in the national press. Ms. Wood graduated from the Vanderbilt University School of Law.
“We are delighted to welcome Jane to the BioReference Laboratories team. She has a distinguished legal career, having counseled a multitude of pathology practices and clinical laboratories across the country; she is considered one of the leading legal experts in the field. Her diverse experience and insight on matters impacting the diagnostics and laboratory industries will be of great value as we continue to deliver high quality diagnostic services to improve patient care,” said Gregory S. Henderson, M.D., Ph.D., President of BioReference Laboratories.